Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Sr-89 for Differentiated Thyroid Cancer with Bone Metastases
NCT05466812Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Strontium chloride in differentiated thyroid cancer (DTC), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
Strontium chloride
03
Conditions
differentiated thyroid cancer (DTC)
Beyond the preview
Go deeper on NCT05466812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466812.